News | Treatment Planning | March 19, 2019

First patient treatment conducted for head and neck cancer patient

ZON-PTC in Clinical Use With RayStation 8B and Hyperscan

March 19, 2019 — Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient using the combination of the treatment planning system (TPS) RayStation from RaySearch in combination with the Mevion S250i Proton Therapy System with Hyperscan Pencil Beam Scanning.

RayStation was the selected treatment planning system in 2017, when the proton therapy center was established. ZON-PTC is a joint undertaking between MAASTRO clinic and the Maastricht University Medical Center (Maastricht UMC+). The center opened early this year, and the first patient treatment has successfully been conducted. The first patient was treated for head and neck cancer, and during the year the center will continue to treat patients with different tumor sites.

The clinic is equipped with Mevion S250i Proton Therapy System with Hyperscan Pencil Beam Scanning. ZON-PTC was one of the first centers to use RayStation 8B clinically.

Geert Bosmans, managing director and medical physicist, at ZON-PTC, said, “We have used RayStation clinically since 2017 and are very satisfied with our selection. RayStation is a very smooth and efficient system, presenting treatment plans with excellent quality. The use of RayStation 8B with Mevion’s S250i Proton Therapy System, allows us to reach the full potential of the hardware. We are delighted that the treatments have gone so well and are looking forward to a successful collaboration with RaySearch.”

For more information: www.raysearchlabs.com

Related Content

News | Radiation Therapy

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American ...

Time October 19, 2021
arrow
News | PET Imaging

October 19, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2021
arrow
News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
News | Radiation Therapy

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Feature | Radiation Therapy

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
Subscribe Now